{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T17:24:21Z","timestamp":1786123461440,"version":"build-2736575974"},"reference-count":96,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,4]]},"abstract":"<jats:p>Cancer-related coagulation abnormalities are characterized by complex dysregulation of the hemostatic system, predisposing patients to increased risk of thrombotic and hemorrhagic complications and associated increased morbidity and mortality. Advances in anticancer therapies with improved outcomes have led to better survival and older age of patients living with or having survived cancer. There is also a significant increase in the number of patients diagnosed with cancer. All these factors will increase the number of patients presenting for surgical procedures, both cancer-related and noncancer related. It is important for the anesthesiologist to understand the magnitude of cancer-related coagulation derangement, its types, pathophysiology, and clinical presentation, to optimize the perioperative management of this high-risk rapidly growing patient population.<\/jats:p>","DOI":"10.1213\/ane.0000000000007286","type":"journal-article","created":{"date-parts":[[2024,12,4]],"date-time":"2024-12-04T13:01:06Z","timestamp":1733317266000},"page":"860-872","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":7,"title":["Cancer-Related Coagulopathy and Perioperative Considerations"],"prefix":"10.1213","volume":"140","author":[{"given":"Seema P.","family":"Deshpande","sequence":"first","affiliation":[{"name":"From the Department of Anesthesiology, University of Maryland School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reney A.","family":"Henderson","sequence":"additional","affiliation":[{"name":"From the Department of Anesthesiology, University of Maryland School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aniruddh U.","family":"Ajith","sequence":"additional","affiliation":[{"name":"Medical Scientist Training Program (MSTP), University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann B.","family":"Zimrin","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Maryland Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine, Baltimore, Maryland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brittney","family":"Williams","sequence":"additional","affiliation":[{"name":"From the Department of Anesthesiology, University of Maryland School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,12,4]]},"reference":[{"key":"R1-20250314","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1055\/s-0039-1693472","article-title":"Cancer-associated thrombosis: a two-way street.","volume":"45","author":"Sharma","year":"2019","journal-title":"Semin Thromb Hemost"},{"key":"R2-20250314","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/j.jtha.2023.02.029","article-title":"Cancer-associated thrombosis: enhanced awareness and pathophysiologic complexity.","volume":"21","author":"Falanga","year":"2023","journal-title":"J Thromb Haemost"},{"issue":"Suppl 2","key":"R3-20250314","doi-asserted-by":"crossref","first-page":"S70","DOI":"10.1016\/S0049-3848(14)50012-6","article-title":"Cancer-related coagulopathies.","volume":"133","author":"Levi","year":"2014","journal-title":"Thromb Res"},{"key":"R4-20250314","doi-asserted-by":"crossref","first-page":"5650","DOI":"10.3390\/jcm11195650","article-title":"Pulmonary embolism in the cancer associated thrombosis landscape.","volume":"11","author":"Poenou","year":"2022","journal-title":"J Clin Med"},{"key":"R5-20250314","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1038\/sj.bjc.6605883","article-title":"Hospitalisation for venous thromboembolism in cancer patients and the general population: a population-based cohort study in Denmark, 1997-2006.","volume":"103","author":"Cronin-Fenton","year":"2010","journal-title":"Br J Cancer"},{"key":"R6-20250314","doi-asserted-by":"crossref","first-page":"2822","DOI":"10.1002\/cncr.21496","article-title":"Risk factors for chemotherapy-associated venous thromboembolism in a prospective observational study.","volume":"104","author":"Khorana","year":"2005","journal-title":"Cancer"},{"key":"R7-20250314","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1001\/jama.293.6.715","article-title":"Malignancies, prothrombotic mutations, and the risk of venous thrombosis.","volume":"293","author":"Blom","year":"2005","journal-title":"JAMA"},{"key":"R8-20250314","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/01.sla.0000193959.44677.48","article-title":"A clinical outcome-based prospective study on venous thromboembolism after cancer surgery: the @RISTOS project.","volume":"243","author":"Agnelli","year":"2006","journal-title":"Ann Surg"},{"key":"R9-20250314","doi-asserted-by":"crossref","first-page":"380","DOI":"10.3390\/cancers10100380","article-title":"Cancer-associated thrombosis: an overview of mechanisms, risk factors, and treatment.","volume":"10","author":"Abdol Razak","year":"2018","journal-title":"Cancers"},{"key":"R10-20250314","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jaccao.2021.03.001","article-title":"Venous and arterial thromboembolism in patients with cancer: JACC: CardioOncology state-of-the-art review.","volume":"3","author":"Gervaso","year":"2021","journal-title":"JACC CardioOncol"},{"key":"R11-20250314","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1080\/10428190802714024","article-title":"Hemorrhagic complications in patients with advanced hematological malignancies followed at home: an Italian experience.","volume":"50","author":"Cartoni","year":"2009","journal-title":"Leuk Lymphoma"},{"key":"R12-20250314","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1055\/s-0039-1687890","article-title":"Disseminated intravascular coagulation in cancer: an update.","volume":"45","author":"Levi","year":"2019","journal-title":"Semin Thromb Hemost"},{"key":"R13-20250314","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s00134-023-06980-6","article-title":"How to manage coagulopathies in critically ill patients.","volume":"49","author":"Helms","year":"2023","journal-title":"Intensive Care Med"},{"key":"R14-20250314","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/jth.12075","article-title":"Coagulation and cancer: biological and clinical aspects.","volume":"11","author":"Falanga","year":"2013","journal-title":"J Thromb Haemost"},{"key":"R15-20250314","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/MOH.0000000000000072","article-title":"The coagulopathy of cancer.","volume":"21","author":"Falanga","year":"2014","journal-title":"Curr Opin Hematol"},{"issue":"suppl 1","key":"R16-20250314","doi-asserted-by":"crossref","first-page":"S89","DOI":"10.1016\/S0049-3848(16)30105-0","article-title":"Risk of thrombosis in cancer and the role of supportive care (transfusion, catheters, and growth factors).","volume":"140","author":"Castaman","year":"2016","journal-title":"Thromb Res"},{"issue":"Suppl 1","key":"R17-20250314","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1016\/S0049-3848(16)30092-5","article-title":"Cancer associated thrombosis: risk factors and outcomes.","volume":"140","author":"Eichinger","year":"2016","journal-title":"Thromb Res"},{"key":"R18-20250314","doi-asserted-by":"crossref","first-page":"4991","DOI":"10.1182\/blood-2009-11-252072","article-title":"Arterial and venous thrombosis in monoclonal gammopathy of undetermined significance and multiple myeloma: a population-based study.","volume":"115","author":"Kristinsson","year":"2010","journal-title":"Blood"},{"key":"R19-20250314","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.jacc.2017.06.047","article-title":"Risk of arterial thromboembolism in patients with cancer.","volume":"70","author":"Navi","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"R20-20250314","doi-asserted-by":"crossref","first-page":"101081","DOI":"10.1016\/j.tranon.2021.101081","article-title":"Thrombotic microangiopathy in oncology \u2013 a review.","volume":"14","author":"Val\u00e9rio","year":"2021","journal-title":"Transl Oncol"},{"key":"R21-20250314","doi-asserted-by":"crossref","first-page":"8599","DOI":"10.1007\/s00520-022-06935-5","article-title":"Thrombotic microangiopathy (TMA) in adult patients with solid tumors: a challenging complication in the era of emerging anticancer therapies.","volume":"30","author":"Font","year":"2022","journal-title":"Support Care Cancer"},{"key":"R22-20250314","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1055\/s-0039-1687893","article-title":"Thrombotic microangiopathy in cancer.","volume":"45","author":"Weitz","year":"2019","journal-title":"Semin Thromb Hemost"},{"key":"R23-20250314","first-page":"649","article-title":"Cancer-associated thrombotic microangiopathy.","volume":"10","author":"Govind Babu","year":"2016","journal-title":"Ecancermedicalscience"},{"key":"R24-20250314","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.clcc.2020.10.004","article-title":"Occurrence and management of thrombocytopenia in metastatic colorectal cancer patients receiving chemotherapy: secondary analysis of data from prospective clinical trials.","volume":"20","author":"Kilpatrick","year":"2021","journal-title":"Clin Colorectal Cancer"},{"key":"R25-20250314","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1016\/j.clinthera.2009.11.020","article-title":"Anemia and thrombocytopenia in patients undergoing chemotherapy for solid tumors: a descriptive study of a large outpatient oncology practice database, 2000\u20132007.","volume":"31 Pt 2","author":"Wu","year":"2009","journal-title":"Clin Ther"},{"key":"R26-20250314","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.2165\/11594310-000000000-00000","article-title":"Thrombocytopenia in adult cancer patients receiving cytotoxic chemotherapy.","volume":"34","author":"ten Berg","year":"2011","journal-title":"Drug Saf"},{"issue":"suppl 1","key":"R28-20250314","doi-asserted-by":"crossref","first-page":"S77","DOI":"10.1016\/j.thromres.2018.01.016","article-title":"Clinical characteristics of disseminated intravascular coagulation in patients with solid and hematological cancers.","volume":"164","author":"Levi","year":"2018","journal-title":"Thromb Res"},{"key":"R29-20250314","doi-asserted-by":"crossref","first-page":"e571","DOI":"10.1097\/HS9.0000000000000571","article-title":"Pathophysiology of coagulopathy in hematological malignancies and in COVID-19.","volume":"5","author":"Levi","year":"2021","journal-title":"HemaSphere"},{"key":"R30-20250314","doi-asserted-by":"crossref","first-page":"e42","DOI":"10.1111\/hae.13639","article-title":"Intravenous immunoglobulin in patients with acquired Von Willebrand syndrome: a single referral centre experience.","volume":"25","author":"Bertolino","year":"2019","journal-title":"Haemophilia"},{"issue":"suppl 1","key":"R31-20250314","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.1016\/S0049-3848(12)70016-6","article-title":"Side effects of anti-angiogenic drugs.","volume":"129","author":"Elice","year":"2012","journal-title":"Thromb Res"},{"key":"R32-20250314","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1001\/archinte.168.21.2377","article-title":"Blood transfusions, thrombosis, and mortality in hospitalized patients with cancer.","volume":"168","author":"Khorana","year":"2008","journal-title":"Arch Intern Med"},{"key":"R33-20250314","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1667\/RR14406.1","article-title":"A review of radiation-induced coagulopathy and new findings to support potential prevention strategies and treatments.","volume":"186","author":"Kennedy","year":"2016","journal-title":"Radiat Res"},{"key":"R34-20250314","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1160\/TH16-08-0615","article-title":"Cancer-associated venous thromboembolism: Burden, mechanisms, and management.","volume":"117","author":"Ay","year":"2017","journal-title":"Thromb Haemost"},{"key":"R35-20250314","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/S0049-3848(16)30353-X","article-title":"The polyphosphate\/factor XII pathway in cancer-associated thrombosis: novel perspectives for safe anticoagulation in patients with malignancies.","volume":"141","author":"Nickel","year":"2016","journal-title":"Thromb Res"},{"issue":"suppl 1","key":"R36-20250314","doi-asserted-by":"crossref","first-page":"S132","DOI":"10.1016\/S0049-3848(12)70033-6","article-title":"Microparticles in tumor progression.","volume":"129","author":"Falanga","year":"2012","journal-title":"Thromb Res"},{"key":"R37-20250314","first-page":"2752","article-title":"Regulation of tissue factor gene expression in the monocyte procoagulant response to endotoxin.","volume":"9","author":"Gregory","year":"1989","journal-title":"Mol Cell Biol"},{"key":"R38-20250314","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0049-3848(92)90286-J","article-title":"Increased levels of tissue plasminogen activator (t-PA) and tissue plasminogen activator inhibitor (PAI) correlate with tumor necrosis factor alpha (TNF alpha)-release in patients suffering from microangiopathy following allogeneic bone marrow transplantation (BMT).","volume":"66","author":"Seeber","year":"1992","journal-title":"Thromb Res"},{"issue":"suppl 2","key":"R39-20250314","doi-asserted-by":"crossref","first-page":"S90","DOI":"10.1016\/S0049-3848(14)50015-1","article-title":"Heparanase multiple effects in cancer.","volume":"133","author":"Nadir","year":"2014","journal-title":"Thromb Res"},{"key":"R40-20250314","first-page":"5588","article-title":"Tumor necrosis factor suppresses transcription of the thrombomodulin gene in endothelial cells.","volume":"8","author":"Conway","year":"1988","journal-title":"Mol Cell Biol"},{"key":"R41-20250314","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.oraloncology.2018.03.004","article-title":"Hypoxia induced EMT: a review on the mechanism of tumor progression and metastasis in OSCC.","volume":"80","author":"Joseph","year":"2018","journal-title":"Oral Oncol"},{"key":"R42-20250314","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1182\/blood-2015-09-671982","article-title":"Diverse roles of cell-specific hypoxia-inducible factor 1 in cancer-associated hypercoagulation.","volume":"127","author":"Evans","year":"2016","journal-title":"Blood"},{"key":"R43-20250314","doi-asserted-by":"crossref","first-page":"94","DOI":"10.3390\/ph11040094","article-title":"Anemia and iron deficiency in cancer patients: role of iron replacement therapy.","volume":"11","author":"Busti","year":"2018","journal-title":"Pharmaceuticals (Basel)"},{"issue":"5, Supplement 1","key":"R44-20250314","doi-asserted-by":"crossref","first-page":"S80","DOI":"10.1016\/j.jamcollsurg.2021.07.146","article-title":"Neuraxial and regional anesthesia reduces the risk of venous thromboembolism in general surgery patients.","volume":"233","author":"Kraemer","year":"2021","journal-title":"J Am Coll Surg"},{"key":"R45-20250314","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/AAP.0000000000000763","article-title":"Regional anesthesia in the patient receiving antithrombotic or thrombolytic therapy: American Society of Regional Anesthesia and Pain Medicine Evidence-Based Guidelines (Fourth Edition).","volume":"43","author":"Horlocker","year":"2018","journal-title":"Reg Anesth Pain Med"},{"key":"R46-20250314","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1634\/theoncologist.2016-0414","article-title":"A predictive score for thrombosis associated with breast, colorectal, lung, or ovarian cancer: the prospective COMPASS\u2013Cancer-Associated thrombosis study.","volume":"22","author":"Gerotziafas","year":"2017","journal-title":"Oncologist"},{"key":"R47-20250314","doi-asserted-by":"crossref","first-page":"e289","DOI":"10.1016\/S2352-3026(18)30063-2","article-title":"A clinical prediction model for cancer-associated venous thromboembolism: a development and validation study in two independent prospective cohorts.","volume":"5","author":"Pabinger","year":"2018","journal-title":"Lancet Haematol"},{"key":"R48-20250314","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.annonc.2022.12.014","article-title":"Venous thromboembolism in cancer patients: ESMO Clinical Practice Guideline.","volume":"34","author":"Falanga","year":"2023","journal-title":"Ann Oncol"},{"key":"R49-20250314","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.athoracsur.2017.10.013","article-title":"Caprini risk model decreases venous thromboembolism rates in thoracic surgery cancer patients.","volume":"105","author":"Sterbling","year":"2018","journal-title":"Ann Thorac Surg"},{"key":"R50-20250314","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.amjsurg.2009.10.006","article-title":"Risk assessment as a guide for the prevention of the many faces of venous thromboembolism.","volume":"199","author":"Caprini","year":"2010","journal-title":"Am J Surg"},{"key":"R51-20250314","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.jamcollsurg.2013.12.061","article-title":"Reducing postoperative venous thromboembolism complications with a standardized risk-stratified prophylaxis protocol and mobilization program.","volume":"218","author":"Cassidy","year":"2014","journal-title":"J Am Coll Surg"},{"key":"R52-20250314","doi-asserted-by":"crossref","first-page":"3484","DOI":"10.1182\/blood-2002-01-0108","article-title":"Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis.","volume":"100","author":"Prandoni","year":"2002","journal-title":"Blood"},{"key":"R53-20250314","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1160\/TH13-04-0352","article-title":"Platelet count and outcome in patients with acute venous thromboembolism.","volume":"110","author":"Di Micco","year":"2013","journal-title":"Thromb Haemost"},{"key":"R54-20250314","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1097\/SLA.0000000000002074","article-title":"Perioperative pharmacological thromboprophylaxis in patients with cancer: a systematic review and meta-analysis.","volume":"265","author":"Guo","year":"2017","journal-title":"Ann Surg"},{"key":"R55-20250314","doi-asserted-by":"crossref","first-page":"e334","DOI":"10.1016\/S1470-2045(22)00160-7","article-title":"2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19.","volume":"23","author":"Farge","year":"2022","journal-title":"Lancet Oncol"},{"key":"R56-20250314","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1055\/a-1715-5960","article-title":"Management of DOAC in patients undergoing planned surgery or invasive procedure: Italian Federation of Centers for the Diagnosis of Thrombotic Disorders and the Surveillance of the Antithrombotic Therapies (FCSA) Position Paper.","volume":"122","author":"Squizzato","year":"2022","journal-title":"Thromb Haemost"},{"key":"R57-20250314","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1477-9560-11-11","article-title":"Laboratory assessment of rivaroxaban: a review.","volume":"11","author":"Samama","year":"2013","journal-title":"Thromb J"},{"key":"R58-20250314","doi-asserted-by":"crossref","first-page":"991675","DOI":"10.3389\/fcvm.2022.991675","article-title":"The impact of direct oral anticoagulants on viscoelastic testing: a systematic review.","volume":"9","author":"Sahli","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"R59-20250314","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1097\/ALN.0000000000003814","article-title":"Viscoelastic coagulation testing: use and current limitations in perioperative decision-making.","volume":"135","author":"Erdoes","year":"2021","journal-title":"Anesthesiology"},{"key":"R60-20250314","doi-asserted-by":"crossref","first-page":"658","DOI":"10.3390\/diagnostics12030658","article-title":"The non-activated thromboelastometry (NATEM) assay\u2019s application among adults and neonatal\/pediatric population: a systematic review.","volume":"12","author":"Georgiadou","year":"2022","journal-title":"Diagnostics (Basel)"},{"key":"R61-20250314","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.thromres.2014.01.011","article-title":"Assessment of rotation thromboelastometry (ROTEM) parameters in patients with multiple myeloma at diagnosis.","volume":"133","author":"Treli\u0144ski","year":"2014","journal-title":"Thromb Res"},{"key":"R62-20250314","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.jamcollsurg.2012.12.006","article-title":"Persistence of hypercoagulable state after resection of intra-abdominal malignancies.","volume":"216","author":"Thorson","year":"2013","journal-title":"J Am Coll Surg"},{"key":"R63-20250314","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.surg.2013.06.053","article-title":"Pre-existing hypercoagulability in patients undergoing potentially curative cancer resection.","volume":"155","author":"Thorson","year":"2014","journal-title":"Surgery"},{"key":"R64-20250314","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1007\/s12032-008-9129-0","article-title":"Laboratory investigation of hypercoagulability in cancer patients using rotation thrombelastography.","volume":"26","author":"Akay","year":"2009","journal-title":"Med Oncol"},{"key":"R65-20250314","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/j.thromres.2015.03.021","article-title":"Application of ROTEM to assess hypercoagulability in patients with lung cancer.","volume":"135","author":"Davies","year":"2015","journal-title":"Thromb Res"},{"key":"R66-20250314","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/ejh.12992","article-title":"Use of viscoelastic tests to predict clinical thromboembolic events: A systematic review and meta-analysis.","volume":"100","author":"Harahsheh","year":"2018","journal-title":"Eur J Haematol"},{"key":"R67-20250314","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.cacc.2008.01.006","article-title":"Management of surgery-associated bleeding in cancer patients.","volume":"19","author":"Pandya","year":"2008","journal-title":"Curr Anaesth Crit Care"},{"key":"R68-20250314","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.hlc.2012.02.004","article-title":"Cardiac surgery in patients with a history of malignancy: increased complication rate but similar mortality.","volume":"21","author":"Chan","year":"2012","journal-title":"Heart Lung Circ"},{"key":"R69-20250314","first-page":"30","article-title":"Blood product transfusion in adults: indications, adverse reactions, and modifications.","volume":"102","author":"Raval","year":"2020","journal-title":"Am Fam Physician"},{"key":"R70-20250314","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4137\/CGM.S32797","article-title":"Impact of transfusion on cancer growth and outcome.","volume":"9","author":"Goubran","year":"2016","journal-title":"Cancer Growth Metastasis"},{"issue":"Suppl 2","key":"R71-20250314","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1016\/S0049-3848(14)50010-2","article-title":"Supportive transfusion therapy in cancer patients with acquired defects of hemostasis.","volume":"133","author":"Federici","year":"2014","journal-title":"Thromb Res"},{"key":"R72-20250314","doi-asserted-by":"crossref","first-page":"e0130122","DOI":"10.1371\/journal.pone.0130122","article-title":"Perioperative blood transfusion promotes worse outcomes of bladder cancer after radical cystectomy: a systematic review and meta-analysis.","volume":"10","author":"Wang","year":"2015","journal-title":"PLoS One"},{"key":"R73-20250314","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1046\/j.1365-2168.2000.01570.x","article-title":"Effects of the combination of blood transfusion and postoperative infectious complications on prognosis after surgery for colorectal cancer. Danish RANX05 Colorectal Cancer Study Group.","volume":"87","author":"Mynster","year":"2000","journal-title":"Br J Surg"},{"key":"R74-20250314","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1002\/bjs.1800750822","article-title":"Blood transfusion and infectious complications following colorectal cancer surgery.","volume":"75","author":"Tartter","year":"1988","journal-title":"Br J Surg"},{"key":"R75-20250314","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/ALN.0000000000000463","article-title":"Practice Guidelines for Perioperative Blood Management: An Updated Report by the American Society of Anesthesiologists Task Force on Perioperative Blood Management.","volume":"122","year":"2015","journal-title":"Anesthesiology"},{"key":"R76-20250314","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1053\/j.jvca.2018.06.001","article-title":"Safety of fibrinogen concentrate and cryoprecipitate in cardiovascular surgery: multicenter database study.","volume":"33","author":"Maeda","year":"2019","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"R77-20250314","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1093\/bja\/aeu364","article-title":"Perioperative administration of fibrinogen does not increase adverse cardiac and thromboembolic events after cardiac surgery.","volume":"114","author":"Fassl","year":"2015","journal-title":"Br J Anaesth"},{"key":"R78-20250314","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1093\/bja\/aes576","article-title":"Time course of haemostatic effects of fibrinogen concentrate administration in aortic surgery.","volume":"110","author":"Solomon","year":"2013","journal-title":"Br J Anaesth"},{"key":"R79-20250314","doi-asserted-by":"crossref","first-page":"e3054","DOI":"10.1136\/bmj.e3054","article-title":"Effect of tranexamic acid on surgical bleeding: systematic review and cumulative meta-analysis.","volume":"344","author":"Ker","year":"2012","journal-title":"BMJ"},{"key":"R80-20250314","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.bjan.2019.06.005","article-title":"Efic\u00e1cia e seguran\u00e7a de antifibrinol\u00edticos em cirurgia oncol\u00f3gica: uma revis\u00e3o sistem\u00e1tica e metan\u00e1lise [Efficacy and safety of antifibrinolytics in oncological surgery: a systematic review and meta-analysis].","volume":"69","author":"Sampaio","year":"2019","journal-title":"Braz J Anesthesiol"},{"key":"R81-20250314","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1097\/EJA.0000000000001803","article-title":"Management of severe peri-operative bleeding: Guidelines from the European Society of Anaesthesiology and Intensive Care: Second update 2022.","volume":"40","author":"Kietaibl","year":"2023","journal-title":"Eur J Anaesthesiol"},{"key":"R82-20250314","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1186\/cc9311","article-title":"Clinical review: Prothrombin complex concentrates--evaluation of safety and thrombogenicity.","volume":"15","author":"S\u00f8rensen","year":"2011","journal-title":"Crit Care"},{"key":"R83-20250314","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1111\/trf.17010","article-title":"Vitamin K antagonist reversal strategies: systematic review and network meta-analysis from the AABB.","volume":"62","author":"Pagano","year":"2022","journal-title":"Transfusion"},{"key":"R84-20250314","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1160\/TH16-04-0266","article-title":"Prothrombin complex concentrates versus fresh frozen plasma for warfarin reversal. A systematic review and meta-analysis.","volume":"116","author":"Chai-Adisaksopha","year":"2016","journal-title":"Thromb Haemost"},{"key":"R85-20250314","doi-asserted-by":"crossref","first-page":"e20230076","DOI":"10.21470\/1678-9741-2023-0076","article-title":"Hemostasis using prothrombin complex concentrate in patients undergoing cardiac surgery: systematic review with meta-analysis.","volume":"39","author":"Li","year":"2024","journal-title":"Braz J Cardiovasc Surg"},{"key":"R86-20250314","doi-asserted-by":"crossref","first-page":"11031","DOI":"10.1038\/s41598-021-90492-0","article-title":"Disseminated intravascular coagulation immediately after trauma predicts a poor prognosis in severely injured patients.","volume":"11","author":"Wada","year":"2021","journal-title":"Sci Rep"},{"key":"R87-20250314","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1111\/jth.12838","article-title":"Management of cancer-associated disseminated intravascular coagulation: guidance from the SSC of the ISTH.","volume":"13","author":"Thachil","year":"2015","journal-title":"J Thromb Haemost"},{"key":"R88-20250314","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1213\/01.ANE.0000117284.25696.64","article-title":"Utility of intraoperative transesophageal echocardiography for diagnosis of pulmonary embolism.","volume":"99","author":"Rosenberger","year":"2004","journal-title":"Anesth Analg"},{"key":"R89-20250314","doi-asserted-by":"crossref","first-page":"2050313X231185209","DOI":"10.1177\/2050313X231185209","article-title":"Case of intraoperative acute pulmonary embolism diagnosed by transesophageal echocardiography under general anesthesia and successfully managed with extracorporeal membrane oxygenation.","volume":"11","author":"Kurachi","year":"2023","journal-title":"SAGE Open Med Case Rep"},{"key":"R90-20250314","doi-asserted-by":"crossref","first-page":"632","DOI":"10.12659\/AJCR.898912","article-title":"Successful management of intraoperative acute bilateral pulmonary embolism in a high grade astrocytoma patient.","volume":"17","author":"Khraise","year":"2016","journal-title":"Am J Case Rep"},{"key":"R91-20250314","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s12871-017-0360-0","article-title":"Management of intra-operative acute pulmonary embolism during general anesthesia: a case report.","volume":"17","author":"Mao","year":"2017","journal-title":"BMC Anesthesiol"},{"key":"R92-20250314","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1051\/ject\/1999314184","article-title":"5-year incidence of thrombocytosis and the effect on heparin dose response and heparin requirements.","volume":"31","author":"Gayoso","year":"1999","journal-title":"J Extra Corpor Technol"},{"key":"R93-20250314","doi-asserted-by":"crossref","first-page":"276","DOI":"10.12998\/wjcc.v12.i2.276","article-title":"Utility of plasma D-dimer for diagnosis of venous thromboembolism after hepatectomy.","volume":"12","author":"Miyake","year":"2024","journal-title":"World J Clin Cases"},{"key":"R94-20250314","doi-asserted-by":"crossref","first-page":"e2354352","DOI":"10.1001\/jamanetworkopen.2023.54352","article-title":"Risk of venous thromboembolic events after surgery for cancer.","volume":"7","author":"Bj\u00f6rklund","year":"2024","journal-title":"JAMA Netw Open"},{"key":"R95-20250314","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1182\/bloodadvances.2020003442","article-title":"American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer. Blood Adv. 2021;5(4):927-974.","volume":"5","author":"Lyman","year":"2021","journal-title":"Blood Adv"},{"key":"R96-20250314","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/EJA.0000000000000729","article-title":"European Guidelines on perioperative venous thromboembolism prophylaxis: Executive summary.","volume":"35","author":"Afshari","year":"2018","journal-title":"Eur J Anaesthesiol"},{"key":"R97-20250314","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.thromres.2021.06.010","article-title":"Extended thromboprophylaxis following major abdominal\/pelvic cancer-related surgery: a systematic review and meta-analysis of the literature.","volume":"204","author":"Knoll","year":"2021","journal-title":"Thromb Res"}],"container-title":["Anesthesia &amp; Analgesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1213\/ANE.0000000000007286","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T14:36:27Z","timestamp":1786113387000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1213\/ANE.0000000000007286"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,4]]},"references-count":96,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1213\/ane.0000000000007286","relation":{},"ISSN":["0003-2999","1526-7598"],"issn-type":[{"value":"0003-2999","type":"print"},{"value":"1526-7598","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,4]]}}}